Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 15;60(5):271-275.
doi: 10.2176/nmc.oa.2019-0243. Epub 2020 Apr 15.

Analysis of Puncture Site-related Complications in Japanese Registry of Neuroendovascular Therapy (JR-NET)3

Masayuki Sato  1 , Yuji Matsumaru  1 , Nobuyuki Sakai  2 ; JR-NET study group affiliations
Affiliations

Analysis of Puncture Site-related Complications in Japanese Registry of Neuroendovascular Therapy (JR-NET)3

Masayuki Sato et al. Neurol Med Chir (Tokyo). .

Abstract

A subgroup analysis of puncture site-related complications listed in the Japanese Registry of NeuroEndovascular Therapy 3, based on retrospective studies, was performed. Puncture site-related complications occurred in 315 (0.73%, average age: 65.2) of 36,708 patients out of all 43,303 registered cases. Carotid artery stenting (CAS, 95 patients, 1.1%, P <0.01) and extracranial percutaneous transluminal angioplasty (PTA, 21 patients, 1.4%, P <0.01) were associated with significantly higher incidence of puncture site-related complications. The incidence of complications correlated with the number of antiplatelet drugs (P <0.001). Although 40% of the puncture complications were treated conservatively, 13% were treated endovascularly and 5% underwent open surgery.

Keywords: endovascular treatment; nationwide survey; puncture-site related complication.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Disclosure

We declare no conflicts of interest. All authors who are members of The Japan Neurosurgical Society (JNS) have registered self-reported COI disclosure statement forms online through the website for JNS members.

Figures

Fig. 1.
Fig. 1.
Univariate analysis of the antiplatelet agent status. The incidence of puncture site-related complications was significantly different between the patients receiving no medications or 1 or 2 drugs, and no medications or 3 drugs.
See this image and copyright information in PMC

References

    1. Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM: Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 34: 723–738, 2011 - PubMed
    1. Sato M, Matsumaru Y, Sakai N, Yoshimura S, JR-NET study group affiliations : Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2. Neurol Med Chir (Tokyo) 54: 17–22, 2014 - PMC - PubMed
    1. Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R: Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures--a randomized controlled trial. Eur J Radiol 61: 332–334, 2007 - PubMed
    1. Vaitkus PT: A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 16: 243–246, 2004 - PubMed
    1. Veasey RA, Large JK, Silberbauer J, et al. : A randomized controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study. Int J Clin Pract 62: 912–918, 2008 - PubMed